Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00471432
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2007-05-08
Brief Title:
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Adult Solid Tumor Protocol Specific |
| Bladder Cancer |
| Breast Cancer |
| Kidney Cancer |
| Lung Cancer |
| Ovarian Cancer |
| Prostate Cancer |
Keywords:
| Name | View |
|---|---|
| male breast cancer | View |
| recurrent prostate cancer | View |
| stage IV prostate cancer | View |
| recurrent renal cell cancer | View |
| stage IV renal cell cancer | View |
| recurrent non-small cell lung cancer | View |
| stage IV non-small cell lung cancer | View |
| recurrent bladder cancer | View |
| stage IV bladder cancer | View |
| recurrent breast cancer | View |
| stage IV breast cancer | View |
| recurrent ovarian epithelial cancer | View |
| stage IV ovarian epithelial cancer | View |
| unspecified adult solid tumor protocol specific | View |